Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastoma.

Mame Daro FayeJacob EasawPaula De RoblesRaman AgnihotramAlexander Torres-VasquezFrederic LamondeKevin PetreccaScott P OwenValerie Panet-RaymondGeorge ShenoudaLuis SouhamiMaryam AzamBushra HossainJad AlkassSiham SabriBassam Abdulkarim

Published in: Neuro-oncology advances (2023)

status and provide a strong rationale to test this combination in future studies.

Keyphrases

newly diagnosed
early stage
locally advanced
current status
renal cell carcinoma
radiation therapy
rectal cancer
metastatic renal cell carcinoma
clinical trial
radiation induced
open label
squamous cell carcinoma
case control
randomized controlled trial